Sort
78,016 grants matching “breast cancer”
NCTN Lead Academic Participating Site at Dana-Farber/Partners Cancer Care
$1,048,778Harold John Burstein · Dana-Farber Cancer Inst · UG1 · FY2024 · CA
Fox Chase Clinical Epidemiology and Validation Center
$1,048,745Paul F. Engstrom · Fox Chase Cancer Center · U01 · FY2009 · CA
Risk Factors for Breast Cancer in Younger Nurses
$1,048,629Walter C. Willett · Harvard School Of Public Health · R01 · FY2015 · CA
IGF::OT::IGF CORE INFRASTURCTURE SUPPORT FOR SURVEILLANCE, EPIDEMIOLOGY AND END RESULTS (SEER)PERIOD OF PERFORMANCE: 05/01/2015 TO 04/30/2016
$1,048,092Antoinette Stroup · Rbhs -Cancer Institute Of New Jersey · N01 · FY2015 · CA
Fred Hutchinson Breast Cancer Clinical Validation Center
$1,047,995Christopher I Li · Fred Hutchinson Cancer Center · U01 · FY2024 · CA
Center for Development of Medications and Biologics for Treatment of the Pregnant Patient and Fetus
$1,047,894Gary D Hankins · University Of Texas Med Br Galveston · U54 · FY2016 · HD
DNA Repair, Cell Cycle Checkpoints and Apoptosis as Targets for Anticancer Drugs
$1,047,789Yves Pommier · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Baptist Memorial Health Care/Mid South NCORP Consortium
$1,047,638Raymond U Osarogiagbon · Baptist Memorial Hospital - Tipton · UG1 · FY2025 · CA
The Role of Cancer-Associated Fibroblasts in Thyroid Carcinoma
$1,047,479Vivian Lee Weiss · Vanderbilt University Medical Center · R01 · FY2025 · CA
BRCA1, DNA damage response and aging
$1,047,427Chuxia Deng · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
The Role of Bioactive Lipids in Inflammation and Cancer
$1,047,419Raymond Nelson Dubois · Mayo Clinic Arizona · P01 · FY2014 · CA
Interventions in Genetic Counseling
$1,047,196Barbara Bowles Biesecker · National Human Genome Research Institute · ZIA · FY2016 · HG
Georgia CaRes
$1,047,137Sharad A. Ghamande · Augusta University · UG1 · FY2024 · CA
Determining the contribution of microbial-derived metabolites to protective immunity in obesity-driven cancer risk.
$1,046,868Liza Makowski Hayes · University Of Tennessee Health Sci Ctr · U01 · FY2025 · CA
Pharmacogenetic Studies
$1,046,660Neil E. Caporaso · Division Of Cancer Epidemiology And Genetics · ZIA · FY2012 · CA
Mechanisms of axon guidance during development
$1,046,341Edward Giniger · National Institute Of Neurological Disorders And Stroke · Z01 · FY2008 · NS
NSABP COMMUNITY CLINICAL ONCOLOGY PROGRAM RESEARCH BASE
$1,046,226Norman Wolmark · Nsabp Foundation, Inc. · U10 · FY2008 · CA
Activating Cell Death Pathways in Breast Cancer Cells
$1,045,773Stanley Lipkowitz · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
Combining single cell approaches and a developmental perspective to discover stem cell control circuits and the cellular and molecular bases of cancer heterogeneity
$1,045,738Geoffrey Myles Wahl · Salk Institute For Biological Studies · R35 · FY2017 · CA
Genomewide association in early-onset breast cancer
$1,045,578Habibul Ahsan · University Of Chicago · U01 · FY2009 · CA
Determining the Fate of Transmembrane Proteins
$1,045,410Allan M Weissman · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Georgia NCI Community Oncology Research Program (NCORP)
$1,045,219Guilherme Cantuaria · Northside Hospital Atlanta · UG1 · FY2016 · CA
Clinical Protocol and Data Management (Core 012)
$1,045,017Dan Toby Vogl · University Of Pennsylvania · P30 · FY2016 · CA
Survey and SEER Data Collection Core
$1,044,936Nancy K Janz · University Of Michigan At Ann Arbor · P01 · FY2014 · CA
Transgenic Models for Prostate and Breast Cancer
$1,044,851Jeffrey E Green · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA